Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gonzalez

Showing results (401-410 of 444) with videos related to

Pageof 45
Sort By:
Carcinogenesis|July 7, 2016
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patientsFrancesco Sclafani, Ian Chau, David Cunningham, et al.
The Journal of Biological Chemistry|September 14, 2017
ZNF143 protein is an important regulator of the myeloid transcription factor C/EBPαDavid Gonzalez, Annouck Luyten, Boris Bartholdy, et al.
Blood|July 5, 2007
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myelomaMatthew W Jenner, Paola E Leone, Brian A Walker, et al.
Frontiers in Oncology|July 15, 2022
<i>TP53</i> Mutations Identified Using NGS Comprise the Overwhelming Majority of <i>TP53</i> Disruptions in CLL: Results From a Multicentre StudyMark A Catherwood, Dorte Wren, Laura Chiecchio, et al.
Seminars in Oncology|December 18, 2017
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer PatientsEttore Capoluongo, Gillian Ellison, José Antonio López-Guerrero, et al.
Cell Reports. Medicine|February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trialJames Larkin, Richard Marais, Nuria Porta, et al.
British Journal of Haematology|January 25, 2003
Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea phase II trialJuan José Lahuerta, Carlos Grande, Joaquín Martínez-Lopez, et al.
Molecular Oncology|December 1, 2021
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomasChristopher I Milton, Joanna Selfe, Ewa Aladowicz, et al.
British Journal of Haematology|March 9, 2011
Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemiaLetizia Foroni, Gill Wilson, Gareth Gerrard, et al.
The Journal of Biological Chemistry|April 10, 2010
A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic targetChen He, George P Nora, Eric L Schneider, et al.
Pageof 45

Showing results (401-410 of 444) with videos related to

Sort By:
Pageof 45
Carcinogenesis|July 7, 2016
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patientsFrancesco Sclafani, Ian Chau, David Cunningham, et al.
The Journal of Biological Chemistry|September 14, 2017
ZNF143 protein is an important regulator of the myeloid transcription factor C/EBPαDavid Gonzalez, Annouck Luyten, Boris Bartholdy, et al.
Blood|July 5, 2007
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myelomaMatthew W Jenner, Paola E Leone, Brian A Walker, et al.
Frontiers in Oncology|July 15, 2022
<i>TP53</i> Mutations Identified Using NGS Comprise the Overwhelming Majority of <i>TP53</i> Disruptions in CLL: Results From a Multicentre StudyMark A Catherwood, Dorte Wren, Laura Chiecchio, et al.
Seminars in Oncology|December 18, 2017
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer PatientsEttore Capoluongo, Gillian Ellison, José Antonio López-Guerrero, et al.
Cell Reports. Medicine|February 28, 2024
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trialJames Larkin, Richard Marais, Nuria Porta, et al.
British Journal of Haematology|January 25, 2003
Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea phase II trialJuan José Lahuerta, Carlos Grande, Joaquín Martínez-Lopez, et al.
Molecular Oncology|December 1, 2021
FGF7-FGFR2 autocrine signaling increases growth and chemoresistance of fusion-positive rhabdomyosarcomasChristopher I Milton, Joanna Selfe, Ewa Aladowicz, et al.
British Journal of Haematology|March 9, 2011
Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemiaLetizia Foroni, Gill Wilson, Gareth Gerrard, et al.
The Journal of Biological Chemistry|April 10, 2010
A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic targetChen He, George P Nora, Eric L Schneider, et al.
Pageof 45